{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T10:46:36Z","timestamp":1648982796977},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["burnsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.burns.2013.10.027","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T06:30:44Z","timestamp":1385447444000},"page":"903-908","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hospital management and clinical factors associated with ophthalmic involvement in Toxic Epidermal Necrolysis"],"prefix":"10.1016","volume":"40","author":[{"given":"Belinda W.","family":"Hii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick D.","family":"Mahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Wasiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eldho","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle A.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.burns.2013.10.027_bib0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"A clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2013.10.027_bib0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD 95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.burns.2013.10.027_bib0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens\u2013Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.burns.2013.10.027_bib0020","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2011.09.029","article-title":"Toxic epidermal necrolysis: review of pathogenesis and management","volume":"66","author":"Downey","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.burns.2013.10.027_bib0025","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/CCM.0b013e31821201ed","article-title":"Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome: a review","volume":"39","author":"Gerull","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.burns.2013.10.027_bib0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.burns.2009.06.213","article-title":"Toxic epidermal necrolysis (Lyell's disease)","volume":"36","author":"Lissia","year":"2010","journal-title":"Burns"},{"key":"10.1016\/j.burns.2013.10.027_bib0035","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.burns.2013.10.027_bib0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/07853890701753664","article-title":"Stevens\u2013Johnson Syndrome: pathogenesis, diagnosis, management","volume":"40","author":"Hazin","year":"2007","journal-title":"Ann Med"},{"key":"10.1016\/j.burns.2013.10.027_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000070938","article-title":"Dermatological and ophthalmological sequels in toxic epidermal necrolysis","volume":"207","author":"Magina","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.burns.2013.10.027_bib0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.bcr.0000194268.01514.f8","article-title":"Long-term follow-up of patients treated for toxic epidermal necrolysis","volume":"27","author":"Oplatek","year":"2006","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2013.10.027_bib0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.BCR.0000150215.78220.79","article-title":"Late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a burn center","volume":"26","author":"Haber","year":"2005","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.burns.2013.10.027_bib0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ajo.2010.04.026","article-title":"Ophthalmic manifestations of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis and relation to SCORTEN","volume":"150","author":"Morales","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.burns.2013.10.027_bib0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","article-title":"Erythema multiforme, Stevens\u2013Jonson syndrome and toxic epidermal necrolysis: acute ocular manifestations, causes and management","volume":"26","author":"Chang","year":"2007","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.burns.2013.10.027_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/archdermatol.2009.540","article-title":"Risk factors for the development of ocular complications of Stevens\u2013Johsnon syndrome and toxic epidermal necrolysis","volume":"145","author":"Gueudry","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2013.10.027_bib0075","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","article-title":"Analysis of the acute ophthalmic manifestations of the erythema multiforme\/Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis disease spectrum","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.burns.2013.10.027_bib0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1542-0124(12)70014-9","article-title":"Management of the late ocular sequelae of Stevens\u2013Johnson syndrome","volume":"1","author":"Wall","year":"2003","journal-title":"Ocul Surf"},{"key":"10.1016\/j.burns.2013.10.027_bib0085","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","article-title":"Ocular manifestations and complications of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: an Asian series","volume":"62","author":"Yip","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.burns.2013.10.027_bib0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/BCR.0b013e31822b0f29","article-title":"Management of ocular conditions in the burn unit: thermal and chemical burns and Stevens\u2013Johnson Syndrome\/Toxic Epidermal Necrolysis","volume":"32","author":"Lin","year":"2011","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2013.10.027_bib0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1542-0124(12)70273-2","article-title":"The ophthalmologic management of acute Stevens\u2013Johnson syndrome","volume":"6","author":"Gregory","year":"2008","journal-title":"Ocul Surf"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417913003598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417913003598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T18:53:28Z","timestamp":1539024808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417913003598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0305417913003598"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2013.10.027","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospital management and clinical factors associated with ophthalmic involvement in Toxic Epidermal Necrolysis","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2013.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}